Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds

References

• Glassman A, Giedion U, Smith PC. What’s in, what’s out? Designing benefits for universal health coverage. Washington (DC): Center for Global Development; 2017. https://www.cgdev.org/sites/default/files/whats-in-whats-out-designing-benefits-final.pdf
   Google Scholar
• University of York. Cost-effectiveness threshold [online]. York: York Health Economics Consortium; 2016.
   Google Scholar
• Vallejo-Torres L, García-Lorenzo B, Castilla I, et al. On the estimation of the cost-effectiveness threshold: why, what, how? [Article]. Value Health. 2016;19(5):558–566. doi: 10.1016/j.jval.2016.02.020
   PubMed Web of Science ®Google Scholar
• YL C, Blecher M, Chalkidou K, et al. What next after GDP-based cost-effectiveness thresholds? [version 1; peer review: 2 approved]. Gates Open Res. 2020;4(176):176. doi: 10.12688/gatesopenres.13201.1
   PubMedGoogle Scholar
• Bertram MY, Lauer JA, De Joncheere K, et al. Cost-effectiveness thresholds: pros and cons [Article]. Bull WHO. 2016;94(12):925–930. doi: 10.2471/BLT.15.164418
   PubMed Web of Science ®Google Scholar
• Thokala P, Ochalek J, Leech AA, et al. Cost-effectiveness thresholds: the past, the present and the future [Article]. PharmacoEconomics. 2018;36(5):509–522. doi: 10.1007/s40273-017-0606-1
   PubMed Web of Science ®Google Scholar
• Edoka IP, Stacey NK. Estimating a cost-effectiveness threshold for health care decision-making in South Africa. Health Policy Plann. 2020;35(5):546–555. doi: 10.1093/heapol/czz152
   PubMed Web of Science ®Google Scholar
• Leech AA, Kim DD, Cohen JT, et al. Use and misuse of cost-effectiveness analysis thresholds in low- and middle-income countries: trends in cost-per-DALY studies [Article]. Value Health. 2018;21(7):759–761. doi: 10.1016/j.jval.2017.12.016
   PubMed Web of Science ®Google Scholar
• Nimdet K, Chaiyakunapruk N, Vichansavakul K, et al. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify ce threshold? [Review]. PLoS One. 2015;10(4):e0122760. doi: 10.1371/journal.pone.0122760
   PubMed Web of Science ®Google Scholar
• Santos AS, Guerra-Junior AA, Godman B, et al. Cost-effectiveness thresholds: methods for setting and examples from around the world [Review]. Expert Rev Pharmacoecon Outcomes Res. 2018;18(3):277–288. doi: 10.1080/14737167.2018.1443810
   PubMed Web of Science ®Google Scholar
• Marseille E, Larson B, Kazi DS, et al. Thresholds for the cost–effectiveness of interventions: alternative approaches [Article]. Bull WHO. 2015;93(2):118–124. doi: 10.2471/BLT.14.138206
   PubMed Web of Science ®Google Scholar
• Robinson LA, Hammitt JK, Chang AY, et al. Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds [Article]. Health Policy Plann. 2017;32(1):141–145. doi: 10.1093/heapol/czw096
   PubMed Web of Science ®Google Scholar
• Cameron D, Ubels J, Norström F. On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review [Review]. Global Health Action. 2018;11(1):1447828. doi: 10.1080/16549716.2018.1447828
   PubMed Web of Science ®Google Scholar
• Watson S, Arulampalam W, Petrou S, et al. The effect of health care expenditure on patient outcomes: evidence from English neonatal care [Article]. Health Econ. 2017;26(12):e274–e284. doi: 10.1002/hec.3503
   PubMed Web of Science ®Google Scholar
• Gallet CA, Doucouliagos H. The impact of healthcare spending on health outcomes: a meta-regression analysis. Soc Sci Med. 2017;179:9–17. doi: 10.1016/j.socscimed.2017.02.024
   PubMed Web of Science ®Google Scholar
• Edney LC, Lomas J, Karnon J, et al. Empirical estimates of the marginal cost of health produced by a healthcare system: methodological considerations from country-level estimates. PharmacoEconomics. 2022 Jan;40(1):31–43.
   PubMed Web of Science ®Google Scholar
• York Uo. The York Research Database. 2021.
   Google Scholar
• York Uo. University of York Centre for Reviews and Dissemination; 2021.
   Google Scholar
• Gloria MAJ, Thavorncharoensap M, Chaikledkaew U, et al. A systematic review of demand-side methods of estimating the societal monetary value of health gain. Value Health. 2021 Oct 01;24(10):1423–1434. doi: 10.1016/j.jval.2021.05.018
   PubMed Web of Science ®Google Scholar
• International Monetary Fund. World economic outlook database. 2023.
   Google Scholar
• The World Bank Group. GDP per capita, PPP (current international $). 2023.
   Google Scholar
• Al-Jedai AH, Lomas J, Almudaiheem HY, et al. Informing a cost-effectiveness threshold for Saudi Arabia. J Med Econ. 2023 Jan;26(1):128–138.
   PubMed Web of Science ®Google Scholar
• Claxton K, Martin S, Soares M, et al. Methods for the estimation of the national institute for health and care excellence cost-effectiveness threshold [Article]. Health Technol Assess. 2015;19(14):1–503. doi: 10.3310/hta19140
   PubMed Web of Science ®Google Scholar
• Edney LC, Haji Ali Afzali H, Cheng TC, et al. Estimating the reference incremental cost-effectiveness ratio for the Australian health system [Article]. PharmacoEconomics. 2018;36(2):239–252. doi: 10.1007/s40273-017-0585-2
   PubMed Web of Science ®Google Scholar
• Espinosa O, Rodríguez-Lesmes P, Orozco L, et al. Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia. Health Policy Plan. 2022 Mar 4;37(3):359–368. doi: 10.1093/heapol/czab146
   PubMed Web of Science ®Google Scholar
• Lomas J, Martin S, Claxton K. Estimating the marginal productivity of the English National health Service from 2003 to 2012 [Article]. Value Health. 2019;22(9):995–1002. doi: 10.1016/j.jval.2019.04.1926
   PubMed Web of Science ®Google Scholar
• Martin S, Lomas JRS, Grant UOY. Is an ounce of prevention worth a pound of cure? Estimates of the impact of English public health grant on mortality and morbidity [Discussion paper]. BMJ Open. 2020;10(10):e036411. doi: 10.1136/bmjopen-2019-036411
   PubMedGoogle Scholar
• Martin S, Claxton K, Lomas J, et al. How responsive is mortality to locally administered healthcare expenditure? Estimates for England for 2014/15. Appl Health Econ Health Policy. 2022 Jul;20(4):557–572.
   PubMed Web of Science ®Google Scholar
• Martin S, Claxton K, Lomas J. et al. The impact of different types of NHS expenditure on health: marginal cost per QALY estimates for England for 2016/17. Health Policy. 2023 Jun;132:104800.
   PubMed Web of Science ®Google Scholar
• Martin S, Lomas J, Claxton K, et al. How effective is marginal healthcare expenditure? New evidence from England for 2003/04 to 2012/13. Appl Health Econ Health Policy. 2021 Nov;19(6):885–903.
   PubMed Web of Science ®Google Scholar
• Martin S, Rice N, Smith PC. Does health care spending improve health outcomes? Evidence from English programme budgeting data [Article]. J Health Econ. 2008;27(4):826–842. doi: 10.1016/j.jhealeco.2007.12.002
   PubMed Web of Science ®Google Scholar
• Moler-Zapata S, Kreif N, Ochalek J, et al. Estimating the health effects of Expansions in health expenditure in Indonesia: a dynamic panel data approach. Appl Health Econ Health Policy. 2022 Nov;20(6):881–891.
   PubMed Web of Science ®Google Scholar
• Ochalek J, Lomas J. Reflecting the health opportunity costs of funding decisions within value frameworks: initial estimates and the need for further research. Clin Ther. 2020 Jan;42(1):44–59.e2. doi: 10.1016/j.clinthera.2019.12.002
   PubMed Web of Science ®Google Scholar
• Ochalek J, Lomas J, Claxton K. Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data [Article]. BMJ Glob Health. 2018;3(6):e000964. doi: 10.1136/bmjgh-2018-000964
   PubMed Web of Science ®Google Scholar
• Ochalek J, Wang H, Gu Y, et al. Informing a cost-effectiveness threshold for health technology assessment in China: a marginal productivity approach. PharmacoEconomics. 2020 Dec;38(12):1319–1331.
   PubMed Web of Science ®Google Scholar
• Siverskog J, Henriksson M. Estimating the marginal cost of a life year in Sweden’s public healthcare sector [Article]. Eur J Health Econ. 2019;20(5):751–762. doi: 10.1007/s10198-019-01039-0
   PubMed Web of Science ®Google Scholar
• Vallejo-Torres L, García-Lorenzo B, Serrano-Aguilar P. Estimating a cost-effectiveness threshold for the Spanish NHS [Article]. Health Econ. 2018;27(4):746–761. doi: 10.1002/hec.3633
   PubMed Web of Science ®Google Scholar
• Woods B, Revill P, Sculpher M, et al. Country-level cost-effectiveness thresholds: initial estimates and the need for further research [Article]. Value Health. 2016;19(8):929–935. doi: 10.1016/j.jval.2016.02.017
   PubMed Web of Science ®Google Scholar
• Ariste R, Dimatteo L. Value for money: an evaluation of health spending in Canada [Article]. Int J Health Economics Manag. 2017;17(3):289–310. doi: 10.1007/s10754-016-9204-6
   Web of Science ®Google Scholar
• Boachie MK, Ramu K, Põlajeva T. Public health expenditures and health outcomes: new evidence from Ghana [Article]. Economies. 2018;6(4):58. doi: 10.3390/economies6040058
   Web of Science ®Google Scholar
• Cai L. The cost of an additional disability-free life year for older americans: 1992-2005 [Review]. Health Serv Res. 2013;48(1):218–235. doi: 10.1111/j.1475-6773.2012.01432.x
   PubMed Web of Science ®Google Scholar
• Daroudi R, Akbari Sari A, Nahvijou A, et al. Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds. Cost Eff Resour Alloc. 2021 Feb 4;19(1):7. doi: 10.1186/s12962-021-00260-0
   PubMed Web of Science ®Google Scholar
• Gandjour A. A model-based estimate of the cost-effectiveness threshold in Germany. Appl Health Econ Health Policy. 2023 Jul;21(4):627–635. doi: 10.1007/s40258-023-00803-x
   PubMed Web of Science ®Google Scholar
• Heijink R, Koolman X, Westert GP. Spending more money, saving more lives? The relationship between avoidable mortality and healthcare spending in 14 countries. Eur J Health Econ. 2013;14(3):527–538. doi: 10.1007/s10198-012-0398-3
   PubMed Web of Science ®Google Scholar
• Stadhouders N, Koolman X, van Dijk C, et al. The marginal benefits of healthcare spending in the Netherlands: estimating cost-effectiveness thresholds using a translog production function. Health Econ. 2019 Aug 30;28(11):1331–1344. doi: 10.1002/hec.3946
   PubMed Web of Science ®Google Scholar
• van Baal P, Perry-Duxbury M, Bakx P, et al. A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending [Article]. Health Econ. 2019;28(1):87–100. doi: 10.1002/hec.3831
   PubMed Web of Science ®Google Scholar
• Vanness DJ, Lomas J, Ahn H. A health opportunity cost threshold for cost-effectiveness analysis in the United States. Ann Intern Med. 2020 Nov 3;174(1):25–32. doi: 10.7326/M20-1392
   PubMed Web of Science ®Google Scholar
• Pichon-Riviere A, Drummond M, Palacios A, et al. Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures. Lancet Glob Health. 2023 Jun;11(6):e833–e842.
   PubMed Web of Science ®Google Scholar
• Weaver MR, Joffe J, Ciarametaro M, et al. Health care spending effectiveness: estimates suggest that spending improved US health from 1996 to 2016. Health Aff. 2022 Jul;41(7):994–1004.
   Web of Science ®Google Scholar
• World Health Organization. Global health expenditure database 2020 [cited 2023 Sep 27]. Available from: https://apps.who.int/nha/database/ViewData/Indicators/en
   Google Scholar
• Filmer D, Pritchett L. The impact of public spending on health: does money matter? Soc Sci Med. 1999 Nov;49(10):1309–23. doi: 10.1016/S0277-9536(99)00150-1
   PubMed Web of Science ®Google Scholar
• Sampson C, Zamora B, Watson S, et al. Supply-side cost-effectiveness thresholds: questions for evidence-based policy. Appl Health Econ Health Policy. 2022;20(5):651–667. doi: 10.1007/s40258-022-00730-3
   PubMed Web of Science ®Google Scholar
• Horton S. Cost-effectiveness analysis in disease control priorities. In: Jamison D, Gelband H, and Horton S, et al, editors. Disease control priorities: improving health and reducing poverty. 3rd ed.Washington (DC): The International Bank for Reconstruction and Development, The World Bank; 2017. Chapter 7. [cited 2017 Nov 17]. https://www.ncbi.nlm.nih.gov/books/NBK525287/
   Google Scholar
• Ochalek J, Claxton K, Lomas J, et al. Valuing health outcomes: developing better defaults based on health opportunity costs. Expert Rev Pharmacoecon Outcomes Res. 2021 Jul 04;21(4):729–736. doi: 10.1080/14737167.2020.1812387
   PubMed Web of Science ®Google Scholar
• 2023 TNIfHaCENAfhwnouppcfaN. Guide to the methods of technology appraisal 2013. NICE; 2013 [cited 2023 Nov 25]. Available from: https://www.nice.org.uk/process/pmg9/chapter/foreword
   Google Scholar
• Teerawattananon Y, Tritasavit N, Suchonwanich N, et al. The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand. Z Evid Fortbild Qual Gesundhwes. 2014;108(7):397–404. doi: 10.1016/j.zefq.2014.06.017
   PubMedGoogle Scholar
• Wang S, Gum D, Merlin T. Comparing the ICERs in Medicine reimbursement Submissions to NICE and PBAC-Does the presence of an explicit threshold affect the ICER proposed? Value Health. 2018;21(8):938–943. doi: 10.1016/j.jval.2018.01.017
   PubMed Web of Science ®Google Scholar
• Kazibwe J, Gheorghe A, Wilson D, et al. The use of cost-effectiveness thresholds for evaluating health interventions in low- and middle-income countries from 2015 to 2020: a review. Value Health. 2022;25(3):385–389. doi: 10.1016/j.jval.2021.08.014
   PubMed Web of Science ®Google Scholar
• Griffiths M, Maruszczak M, Kusel J. The WHO-choice cost-effectiveness threshold: a country-level analysis of changes over time. Value Health. 2015;18(3):A88. doi: 10.1016/j.jval.2015.03.517
   Web of Science ®Google Scholar